CHOP researchers have discovered a new part of the regulatory cascade responsible for silencing fetal hemoglobin in adult cells.

CHOP has helped launch NCI-backed “Molecular Targets Platform” to streamline and catalyze drug development by harmonizing data about pediatric cancer targets and pathways.

Aligned with CHOP and AHA’s shared mission to improve cardiac care, grant supports research aiming to discover new hormones secreted from the heart.

Robert Sutton, MD, will fulfill leadership role within the Department of Anesthesiology and Critical Care Medicine.

CHOP neurosurgeons collaborated with researchers from the University of Pennsylvania School of Medicine to confirm the presence of these neurons from birth through age 92.

Researchers found daycare attendance was associated with increased emergency department visits, steroid use, and chronic respiratory symptoms in preterm children with chronic lung disease.

CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.

In April, the Office of Community Impact officially welcomed John William Chin as the new CHOP Cares Community Advisory Board Chair. He has served on CHOP Cares Community Advisory Board for the past three years. 

Children living in the neighborhoods around the Children’s Hospital of Philadelphia campus in West and Southwest Philadelphia have experienced more than their fair share of trauma, which only increased with the COVID-19 pandemic and the rise in gun violence. 

Much progress has been made over the last 25 years when it comes to identifying the genetic mutation that is causing a child’s congenital hyperinsulinism (HI).